ABVC BioPharma, Inc. (ABVC)

R&D Expenses

$114.76K

TTM · Period ending: · USD

ABVC logo

ABVC R&D Expenses

Latest reported$114.76K
ABVC TTM R&D Expenses ($0.00 → $114.76K)
High-resolution chart · PNG

ABVC r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

ABVC BioPharma, Inc. R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
114,755
125,324
121,085
124,007
131,942
139,067
179,272
219,477
322,962
797,003
1,062,916
2,486,519
2,650,692
2,669,032
2,693,457
1,457,857
1,415,798
1,241,894
1,003,805
926,901
797,978
578,182
549,657
635,962
770,700
719,387
1,048,553
1,408,363
1,193,638
1,162,566
988,721
405,023
3,476,473
3,437,276
3,214,315
3,193,812
10,067,848
10,050,348
16,525,198
16,500,000
6,500,000
6,500,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.